The demand for enrollment in cancer clinical trials far exceeds the access to patients.
WE’VE CREATED A SOLUTION!
The Just-in-Time Method
Just-In-Time is a rapid start-up process where research sites screen for patients prior to activation. Using the J-I-T approach, Pharmatech can activate research sites on clinical trials within 2-weeks. The purpose of the program is to reduce the burden on research facilities which allows them access a larger number of potential trials when they have an eligible patient. This allows Physicians at Pharmatech J-I-T sites to include clinical trials, not yet opened, in their treatment options for current and future patients.
Take an inside look.
The Just-In-Time program is revolutionizing cancer treatment options. This short video will give you an overview of how quickly and easily you can find and enroll a patient in a personalized treatment program.
How Does “Just-in-Time” Work?
- Research sites screen for patients prior to activation
- Patient identified by pre-screening or by TrialPlus+
- Pharmatech activates site
- Patient qualifies, consents, and enrolls within 10 business days